QURE 12.84 (-0.93%)
NL0010696654BiotechnologyBiotechnology

UniQure (QURE) Stock Highlights

12.84 | -0.93%
2025-02-22 05:22:25
uniQure NV is a gene therapy company. It develops treatment and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntingtons disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Statistics

Range Today
12.53 13.15
Volume Today 740K
Range 1 Year
3.73 19.18
Volume 1 Year 415.49M
Range 3 Year
3.73 28.25
Volume 3 Year 818.61M
Range 10 Year
3.73 82.49
Volume 10 Year 1.56B

Highlights

Market Capitalization 686.14M (small)
Floating Shares 39.96M
Current Price 12.84
Price To Earnings -2.62
Price To Revenue 24.04
Price To Book 11.21
Earnings Per Share -4.95
Payout Ratio 0%

Performance

Latest -0.93%
1 Month -8.09%
3 Months +124.08%
6 Months +88.82%
1 Year +105.77%
3 Years -18.73%
5 Years -79.78%
10 Years -33.3%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.